192 related articles for article (PubMed ID: 20543109)
1. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
[TBL] [Abstract][Full Text] [Related]
2. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
3. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.
Ahmed CM; Dabelic R; Waiboci LW; Jager LD; Heron LL; Johnson HM
J Virol; 2009 Feb; 83(3):1402-15. PubMed ID: 19019946
[TBL] [Abstract][Full Text] [Related]
4. HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion.
Frey KG; Ahmed CM; Dabelic R; Jager LD; Noon-Song EN; Haider SM; Johnson HM; Bigley NJ
J Immunol; 2009 Jul; 183(2):1253-62. PubMed ID: 19542368
[TBL] [Abstract][Full Text] [Related]
5. IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses.
Ahmed CM; Martin JP; Johnson HM
J Immunol; 2007 Apr; 178(7):4576-83. PubMed ID: 17372016
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
Flowers LO; Johnson HM; Mujtaba MG; Ellis MR; Haider SM; Subramaniam PS
J Immunol; 2004 Jun; 172(12):7510-8. PubMed ID: 15187130
[TBL] [Abstract][Full Text] [Related]
7. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
Johnson HM; Lewin AS; Ahmed CM
Front Immunol; 2020; 11():582102. PubMed ID: 33193390
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection.
Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2014 Aug; 21(8):1178-84. PubMed ID: 24964806
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages.
Akhtar LN; Qin H; Muldowney MT; Yanagisawa LL; Kutsch O; Clements JE; Benveniste EN
J Immunol; 2010 Aug; 185(4):2393-404. PubMed ID: 20631305
[TBL] [Abstract][Full Text] [Related]
10. A SOCS1/3 Antagonist Peptide Protects Mice Against Lethal Infection with Influenza A Virus.
Ahmed CM; Dabelic R; Bedoya SK; Larkin J; Johnson HM
Front Immunol; 2015; 6():574. PubMed ID: 26617608
[TBL] [Abstract][Full Text] [Related]
11. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
12. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.
Ahmed CM; Burkhart MA; Subramaniam PS; Mujtaba MG; Johnson HM
J Virol; 2005 May; 79(9):5632-9. PubMed ID: 15827178
[TBL] [Abstract][Full Text] [Related]
13. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression.
Pauli EK; Schmolke M; Wolff T; Viemann D; Roth J; Bode JG; Ludwig S
PLoS Pathog; 2008 Nov; 4(11):e1000196. PubMed ID: 18989459
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response.
Kundu K; Dutta K; Nazmi A; Basu A
Cell Immunol; 2013; 285(1-2):100-10. PubMed ID: 24140964
[TBL] [Abstract][Full Text] [Related]
15. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
16. Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight.
Johnson HM; Ahmed CM
Front Immunol; 2023; 14():1208828. PubMed ID: 38106428
[TBL] [Abstract][Full Text] [Related]
17. Conserved inhibitory role of teleost SOCS-1s in IFN signaling pathways.
Nie L; Xiong R; Zhang YS; Zhu LY; Shao JZ; Xiang LX
Dev Comp Immunol; 2014 Mar; 43(1):23-9. PubMed ID: 24183820
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo.
Shen Z; He H; Wu Y; Li J
PLoS One; 2013; 8(8):e71815. PubMed ID: 23990993
[TBL] [Abstract][Full Text] [Related]
19. SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo.
Starr R; Fuchsberger M; Lau LS; Uldrich AP; Goradia A; Willson TA; Verhagen AM; Alexander WS; Smyth MJ
J Immunol; 2009 Oct; 183(7):4537-44. PubMed ID: 19734231
[TBL] [Abstract][Full Text] [Related]
20. Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation.
Hayashi T; Kaneda T; Toyama Y; Kumegawa M; Hakeda Y
J Biol Chem; 2002 Aug; 277(31):27880-6. PubMed ID: 12023971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
